BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21982514)

  • 21. Alteration of the gut microbiota in tumor necrosis factor-α antagonist-treated collagen-induced arthritis mice.
    Wang B; He Y; Tang J; Ou Q; Lin J
    Int J Rheum Dis; 2020 Apr; 23(4):472-479. PubMed ID: 32100456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
    Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
    Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target.
    Boettger MK; Hensellek S; Richter F; Gajda M; Stöckigt R; von Banchet GS; Bräuer R; Schaible HG
    Arthritis Rheum; 2008 Aug; 58(8):2368-78. PubMed ID: 18668541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells.
    Notley CA; Inglis JJ; Alzabin S; McCann FE; McNamee KE; Williams RO
    J Exp Med; 2008 Oct; 205(11):2491-7. PubMed ID: 18936235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of TACI-Ig with TNF-alpha inhibitor and methotrexate in DBA/1 mice with collagen-induced arthritis.
    Zhang L; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang Y; Zhou A; Wei W
    Eur J Pharmacol; 2013 May; 708(1-3):113-23. PubMed ID: 23454555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
    Bombardieri S; Ferraccioli G; Ferri C; Galeazzi M; Lapadula G; Cerinic MM; Montecucco C; Triolo G; Trotta F; Valentini G
    Reumatismo; 2009; 61 Suppl 1():1-23. PubMed ID: 19999184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of sTNFR-IgGFc fusion gene in endothelial cell and its application in gene therapy for rheumatoid arthritis].
    He J; Yao LH; Chen AJ; Yu H; Jia RQ; Cheng CS; Huan LF; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2006 May; 22(3):378-83. PubMed ID: 16755914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis.
    Quattrocchi E; Walmsley M; Browne K; Williams RO; Marinova-Mutafchieva L; Buurman W; Butler DM; Feldmann M
    J Immunol; 1999 Jul; 163(2):1000-9. PubMed ID: 10395698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.
    McCann FE; Perocheau DP; Ruspi G; Blazek K; Davies ML; Feldmann M; Dean JL; Stoop AA; Williams RO
    Arthritis Rheumatol; 2014 Oct; 66(10):2728-38. PubMed ID: 24965881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
    Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
    Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor.
    Sumariwalla PF; Malfait AM; Feldmann M
    Clin Exp Immunol; 2004 Apr; 136(1):67-75. PubMed ID: 15030516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
    Fleischmann R; Iqbal I
    Drugs Aging; 2007; 24(3):239-54. PubMed ID: 17362051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity study of a hydroxynaphthoquinone fraction from Arnebia euchroma in experimental arthritis.
    Fan H; Yang M; Che X; Zhang Z; Xu H; Liu K; Meng Q
    Fitoterapia; 2012 Oct; 83(7):1226-37. PubMed ID: 22735599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model.
    Setoguchi C; Tsuji F; Katsuta O; Okamoto M; Aono H
    Mod Rheumatol; 2010 Aug; 20(4):381-8. PubMed ID: 20379758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis.
    Hamilton K; Clair EW
    Expert Opin Pharmacother; 2000 Jul; 1(5):1041-52. PubMed ID: 11249494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis.
    Lories RJ; Derese I; de Bari C; Luyten FP
    Arthritis Rheum; 2007 Feb; 56(2):489-97. PubMed ID: 17265484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept.
    Mazzon E; Esposito E; Di Paola R; Muià C; Crisafulli C; Genovese T; Caminiti R; Meli R; Bramanti P; Cuzzocrea S
    Clin Exp Immunol; 2008 Jul; 153(1):136-49. PubMed ID: 18505433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
    Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
    Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis.
    Park YH; Kim HJ; Lee K; Choi Y; Heo TH
    Biochem Biophys Res Commun; 2020 Feb; 522(4):1030-1036. PubMed ID: 31818460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.